Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2002-10-4
pubmed:abstractText
We sought to study the role of MRI-derived cerebral blood flow (CBF) measurements for the prediction of lesion development in acute stroke patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1524-4628
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
33
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2421-5
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:12364732-Acute Disease, pubmed-meshheading:12364732-Adult, pubmed-meshheading:12364732-Aged, pubmed-meshheading:12364732-Aged, 80 and over, pubmed-meshheading:12364732-Blood Flow Velocity, pubmed-meshheading:12364732-Brain, pubmed-meshheading:12364732-Cerebrovascular Circulation, pubmed-meshheading:12364732-Disease Progression, pubmed-meshheading:12364732-Female, pubmed-meshheading:12364732-Fibrinolytic Agents, pubmed-meshheading:12364732-Humans, pubmed-meshheading:12364732-Magnetic Resonance Angiography, pubmed-meshheading:12364732-Magnetic Resonance Imaging, pubmed-meshheading:12364732-Male, pubmed-meshheading:12364732-Middle Aged, pubmed-meshheading:12364732-Predictive Value of Tests, pubmed-meshheading:12364732-Prognosis, pubmed-meshheading:12364732-ROC Curve, pubmed-meshheading:12364732-Sensitivity and Specificity, pubmed-meshheading:12364732-Severity of Illness Index, pubmed-meshheading:12364732-Stroke, pubmed-meshheading:12364732-Thrombolytic Therapy, pubmed-meshheading:12364732-Tissue Plasminogen Activator
pubmed:year
2002
pubmed:articleTitle
Cerebral blood flow predicts lesion growth in acute stroke patients.
pubmed:affiliation
Department of Neuroradiology, University Hospital Hamburg-Eppendorf, University of Hamburg, Hamburg, Germany. fiehler@uke.uni-hamburg.de
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't